- Home
- WNW vs SONN Comparison
WNW vs SONN Comparison
Compare WNW & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- SONN
- Stock Information
- Founded
- WNW 2015
- SONN N/A
- Country
- WNW China
- SONN United States
- Employees
- WNW N/A
- SONN N/A
- Industry
- WNW Catalog/Specialty Distribution
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- SONN Health Care
- Exchange
- WNW Nasdaq
- SONN Nasdaq
- Market Cap
- WNW 26.6M
- SONN 21.4M
- IPO Year
- WNW 2020
- SONN N/A
- Fundamental
- Price
- WNW $1.71
- SONN $4.75
- Analyst Decision
- WNW
- SONN Strong Buy
- Analyst Count
- WNW 0
- SONN 1
- Target Price
- WNW N/A
- SONN $20.00
- AVG Volume (30 Days)
- WNW 17.0K
- SONN 502.2K
- Earning Date
- WNW 11-14-2025
- SONN 12-16-2025
- Dividend Yield
- WNW N/A
- SONN N/A
- EPS Growth
- WNW N/A
- SONN N/A
- EPS
- WNW 9.06
- SONN N/A
- Revenue
- WNW $158,485.00
- SONN $1,000,000.00
- Revenue This Year
- WNW N/A
- SONN $5,376.22
- Revenue Next Year
- WNW N/A
- SONN N/A
- P/E Ratio
- WNW $0.19
- SONN N/A
- Revenue Growth
- WNW N/A
- SONN 1689.52
- 52 Week Low
- WNW $0.95
- SONN $1.08
- 52 Week High
- WNW $70.00
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- WNW 39.54
- SONN 50.93
- Support Level
- WNW $1.62
- SONN $3.52
- Resistance Level
- WNW $1.87
- SONN $5.85
- Average True Range (ATR)
- WNW 0.13
- SONN 0.56
- MACD
- WNW -0.02
- SONN 0.08
- Stochastic Oscillator
- WNW 21.13
- SONN 53.58
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.